Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703 is a research paper published in Journal of Clinical Oncology (2025). On theSindex it has a DataRank of 0.330. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI NIH HHS
Grant: U10 HL069294
NHLBI NIH HHS
Grant: UG1 HL069278
NHLBI NIH HHS
Grant: UG1 HL069310
NHLBI NIH HHS
Grant: U24 HL138660
NHLBI NIH HHS
Grant: P01 HL158505
NCI NIH HHS
Grant: U24 CA076518
NHLBI NIH HHS
Grant: UG1 HL069315
NHLBI NIH HHS
Grant: UG1 HL138645
NCI NIH HHS
Grant: P30 CA008748
NHLBI NIH HHS
Grant: UG1 HL069290
FWCI
7.13
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals